Dongwha Pharm Co Ltd
KRX:000020

Watchlist Manager
Dongwha Pharm Co Ltd Logo
Dongwha Pharm Co Ltd
KRX:000020
Watchlist
Price: 6 290 KRW -1.41% Market Closed
Market Cap: 175.7B KRW

Intrinsic Value

The intrinsic value of one Dongwha Pharm Co Ltd stock under the Base Case scenario is 7 478.91 KRW. Compared to the current market price of 6 290 KRW, Dongwha Pharm Co Ltd is Undervalued by 16%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
7 478.91 KRW
Undervaluation 16%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Dongwha Pharm Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about Dongwha Pharm Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Dongwha Pharm Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Dongwha Pharm Co Ltd.

Explain Valuation
Compare Dongwha Pharm Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Dongwha Pharm Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Dongwha Pharm Co Ltd

Current Assets 232B
Cash & Short-Term Investments 27.7B
Receivables 100.5B
Other Current Assets 103.8B
Non-Current Assets 410.6B
Long-Term Investments 70.1B
PP&E 245.4B
Intangibles 82.6B
Other Non-Current Assets 12.5B
Current Liabilities 142.6B
Accounts Payable 41.6B
Accrued Liabilities 15.4B
Short-Term Debt 32.5B
Other Current Liabilities 53.1B
Non-Current Liabilities 123.3B
Long-Term Debt 68.5B
Other Non-Current Liabilities 54.8B
Efficiency

Free Cash Flow Analysis
Dongwha Pharm Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Dongwha Pharm Co Ltd

Revenue
481.5B KRW
Cost of Revenue
-264.7B KRW
Gross Profit
216.8B KRW
Operating Expenses
-211.7B KRW
Operating Income
5.1B KRW
Other Expenses
1.2B KRW
Net Income
6.3B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

Dongwha Pharm Co Ltd's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin
Sustainable 3Y Average Gross Margin
Declining Net Margin
Declining Gross Margin
42/100
Profitability
Score

Dongwha Pharm Co Ltd's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Dongwha Pharm Co Ltd's solvency score is 66/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Low D/E
Long-Term Solvency
Short-Term Solvency
66/100
Solvency
Score

Dongwha Pharm Co Ltd's solvency score is 66/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Dongwha Pharm Co Ltd

There are no price targets for Dongwha Pharm Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Dongwha Pharm Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Dongwha Pharm Co Ltd stock?

The intrinsic value of one Dongwha Pharm Co Ltd stock under the Base Case scenario is 7 478.91 KRW.

Is Dongwha Pharm Co Ltd stock undervalued or overvalued?

Compared to the current market price of 6 290 KRW, Dongwha Pharm Co Ltd is Undervalued by 16%.

Back to Top